Zhen Liang
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems 7
- Advancements in Transdermal Drug Delivery 2
- General Dentistry top 10%
- Oncology top 10%
- COVID-19 and healthcare impacts 8
-
- Ocular Surface and Contact Lens 7
- Rehabilitation top 10%
-
- COVID-19 Clinical Research Studies 4
-
- Essential Oils and Antimicrobial Activity 3
-
- Bone Tissue Engineering Materials 2
-
- Diabetic Foot Ulcer Assessment and Management 2
Zhen Liang
24 papers receiving 745 citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Pharmaceutical Science 112
- General Dentistry 20
- Oncology 258
- Public Health, Environmental and Occupational Health 220
- Rehabilitation 47
Countries citing papers authored by Zhen Liang
This map shows the geographic impact of Zhen Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhen Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhen Liang more than expected).
Fields of papers citing papers by Zhen Liang
This network shows the impact of papers produced by Zhen Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhen Liang. The network helps show where Zhen Liang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhen Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | Artificial intelligence using a latent diffusion model enables the generation of diverse and potent antimicrobial peptidesbreakdown → | 2025 | 26 |
| 4 | 2024 | 7 | |
| 5 | 2023 | 13 | |
| 6 | 2021 | 21 | |
| 7 | 2021 | 31 | |
| 8 | 2021 | 14 | |
| 9 | 2021 | 3 | |
| 10 | 2020 | 26 | |
| 11 | 2020 | 6 | |
| 12 | 2020 | 19 | |
| 13 | 2020 | 158 | |
| 14 | 2020 | 53 | |
| 15 | 2020 | 163 | |
| 16 | 2020 | 15 | |
| 17 | 2020 | 4 | |
| 18 | 2018 | 17 | |
| 19 | 2016 | 9 | |
| 20 | 2011 | 34 |
About Zhen Liang
Zhen Liang is a scholar working on Pharmaceutical Science, Ophthalmology and Oncology, having authored 26 papers that have together received 765 indexed citations. Recurring topics across this work include COVID-19 and healthcare impacts (8 papers), Ocular Surface and Contact Lens (7 papers), Advanced Drug Delivery Systems (7 papers), COVID-19 Clinical Research Studies (4 papers), Essential Oils and Antimicrobial Activity (3 papers), Advancements in Transdermal Drug Delivery (2 papers), Bone Tissue Engineering Materials (2 papers) and Diabetic Foot Ulcer Assessment and Management (2 papers). The work is most often cited by research in Pharmaceutical Science (112 citations), General Dentistry (20 citations) and Oncology (258 citations). Zhen Liang has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Wilson Wang, Shirley Beng Suat Ooi, Diarmuid Murphy, James Hoi Po Hui, Jingjing Yang, Ping Lü, Jingguo Li, Tianyang Zhou, Lei Han and Siyu He. Their work appears in journals such as The Lancet, Journal of Bone and Joint Surgery and Annals of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.